Japanese Pharma, Hungry For Global Deals, Can Fill Gap Of Shrinking Partners - PharmAsia Summit
This article was originally published in The Pink Sheet Daily
Executive Summary
The deal appetite and the changing trend toward risk-sharing deals is making Japanese pharma attractive partners for U.S. biotechs, said a panel at Elsevier Business Intelligence's PharmAsia Summit in San Francisco.